Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Carmen García-Muñoz"'
1
Akademický článek
Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs
Autor: Andrea Lázaro Cebas, José Manuel Caro Teller, Carmen García Muñoz, Carlos González Gómez, José Miguel Ferrari Piquero, Carlos Lumbreras Bermejo, José Antonio Romero Garrido, Juana Benedí González
Publikováno v: BMC Health Services Research, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Patient education on pharmacological treatment could reduce readmissions. Our objective was to carry out a pharmacist intervention focused on providing information about high-risk medications to chronic patients and to analyse its
Externí odkaz: https://doaj.org/article/f49b14ba5bae4a6899bced58d2d6280b
Zobrazit plný text záznamu
4
[Controlled supply of tocilizumab during the COVID-19 pandemic and its influence on the treatment of rheumatological patients.]
Autor: Sara, Ortiz Pérez, José Manuel, Caro Teller, Carmen, García Muñoz, Paola, Herraiz Robles, Fernando, Lozano Morillo, José Luis, Pablos Álvarez, José Miguel, Ferrari Piquero
Publikováno v: Revista espanola de salud publica. 95
Intravenous (IV) tocilizumab has been used to stop the inflammatory phase of SARS-CoV-2 infection. To preserve the largest number of IV units for this use, the Spanish Agency for Medicines and Health Products (AEMPS) carried out a controlled supply o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::03a3d19ba943d9b71fda41e596c30cdf
https://pubmed.ncbi.nlm.nih.gov/34803159
Zobrazit plný text záznamu
6
Clinical impact of gastric acid suppressing medication on the effectiveness of tyrosine kinase inhibitors in lung cancer patients
Autor: Marcos, Nieves Sedano, José, Manuel Caro Teller, Carmen, García Muñoz, Delia, Fernandez Redondo, Santiago, Ponce Aix, Miguel, Menéndez Orenga, José, Miguel Ferrari Piquero
Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 23(3)
Erlotinib and gefitinib are both tyrosine kinase inhibitors (TKIs) approved for the treatment of non-small cell lung cancer (NSCLC). Although it is well known that the increase of gastric pH may decrease the solubility of TKIs, there is limited evide
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c7f700c5c9c1a159184305115ecc718c
https://pubmed.ncbi.nlm.nih.gov/30003732
Zobrazit plný text záznamu
9
Akademický článek
Use of oral antineoplastic in special situations in a third level hospital: real life results
Autor: José Miguel Ferrari-Piquero, Pedro Pablo Rodriguez-Quesada, Carmen Garcia-Muñoz
Publikováno v: Farmacia Hospitalaria, Vol 42, Iss 01, Pp 5-9 (2018)
Objective: To analyse the effectiveness and safety of oral antineoplastic drugs (ANEOs) that are authorized in special situations in a third-level hospital and to compare the results obtained with the clinical evidence used for this authorization. M
Externí odkaz: https://doaj.org/article/3574fb80a3c44e71af96653a352cb9cd
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje